You have 9 free searches left this month | for more free features.

Condition

Breast Cancer (1)

Cushing Disease (1)

Non-small Cell Lung Cancer (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Cedars-Sinai Medical Center (1)

Cyclacel Pharmaceuticals, Inc. (1)

M.D. Anderson Cancer Center (1)

Collaborator

National Institutes of Health (NIH) (1)

Intervention

seliciclib (3)

liposomal doxorubicin (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

seliciclib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cushing Disease Trial in Los Angeles (Seliciclib)

Active, not recruiting

Cushing Disease

Seliciclib

Los Angeles, California

Cedars-Sinai Medical Center

May 24, 2022

NSCLC Trial in United States (seliciclib, )

Terminated

Non-small Cell Lung Cancer

seliciclib
placebo

Tucson, Arizona
+19 more

Dec 7, 2021

Breast Cancer Trial (Liposomal Doxorubicin, Seliciclib)

Withdrawn

Breast Cancer

Liposomal Doxorubicin
Seliciclib

(no location specified)

Jun 22, 2012